Literature DB >> 3213651

Operative treatment of Chiari malformation with syringomyelia.

H Tokuno1, A Hakuba, T Suzuki, S Nishimura.   

Abstract

The authors have operated on and reviewed 38 patients with Chiari malformation. By the introduction of our new operative method, Gardner's operation combined with expansive suboccipital cranioplasty, the operative results were improved.

Entities:  

Mesh:

Year:  1988        PMID: 3213651     DOI: 10.1007/978-3-7091-8978-8_5

Source DB:  PubMed          Journal:  Acta Neurochir Suppl (Wien)


  6 in total

1.  A simple technique for expansive suboccipital cranioplasty following foramen magnum decompression for the treatment of syringomyelia associated with Chiari I malformation.

Authors:  Masakazu Takayasu; Teruhide Takagi; Masahito Hara; Masaoki Anzai
Journal:  Neurosurg Rev       Date:  2004-05-08       Impact factor: 3.042

Review 2.  Pathogenesis of syringomyelia associated with Chiari type 1 malformation: review of evidences and proposal of a new hypothesis.

Authors:  Izumi Koyanagi; Kiyohiro Houkin
Journal:  Neurosurg Rev       Date:  2010-06-08       Impact factor: 3.042

Review 3.  [Spinal disorders and associated CNS anomalies - tethered cord and Arnold-Chiari malformation].

Authors:  M Cabraja; U-W Thomale; P Vajkoczy
Journal:  Orthopade       Date:  2008-04       Impact factor: 1.087

4.  The surgical treatment of Chiari I malformation.

Authors:  J Klekamp; U Batzdorf; M Samii; H W Bothe
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

5.  Factors contributing improvement of syringomyelia and surgical outcome in type I Chiari malformation.

Authors:  Young Seok Park; Dong-Seok Kim; Kyu-Won Shim; Jung-Hee Kim; Joong-Uhn Choi
Journal:  Childs Nerv Syst       Date:  2008-12-05       Impact factor: 1.475

6.  Effects of surgery on the sensory deficits of syringomyelia and predictors of outcome: a long term prospective study.

Authors:  N Attal; F Parker; M Tadié; N Aghakani; D Bouhassira
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-07       Impact factor: 10.154

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.